Stephen T. Worland - 15 Nov 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Issuer symbol
EFTR on OTC
Transactions as of
15 Nov 2022
Net transactions value
+$2,832
Form type
4
Filing time
16 Nov 2022, 17:27:41 UTC
Previous filing
22 Jun 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $2,832 +6,047 +2.8% $0.4684 221,025 15 Nov 2022 Direct F1
holding EFTR Common Stock 562,339 15 Nov 2022 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.